Cargando…

1798. Phenotypic and Genotypic Impact of Antibiotic Stewardship Intervention on Daptomycin-Nonsusceptible Enterococcus faecium (DNSE) Clinical Isolates

BACKGROUND: Since its introduction in 2009, use of daptomycin for treatment of enterococcal infections has resulted in the emergence of DNSE. Between 2009 and 2013, daptomycin nonsusceptibility among E. faecium was closely associated with emergence of a unique and dominant clone ST736 in our institu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhand, Abhay, Lee, Leslie, Feola, Nicholas, Chen, Donald, Dimitrova, Nevenka, Yin, Changhong, Huang, Weihua, Fallon, John, Wang, Guiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254808/ http://dx.doi.org/10.1093/ofid/ofy210.1454

Ejemplares similares

Evolution and mutations predisposing to daptomycin resistance in vancomycin-resistant Enterococcus faecium ST736 strains
por: Wang, Guiqing, et al.
Publicado: (2018)

478 Daptomycin Susceptible vs Nonsusceptible Enterococcus faecium Bacteremias: Comparison of Clinical and Microbiological Outcomes
por: Lee, Spencer, et al.
Publicado: (2014)

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2023)

Optimizing a Whole-Genome Sequencing Data Processing Pipeline for Precision Surveillance of Health Care-Associated Infections
por: Huang, Weihua, et al.
Publicado: (2019)

Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
por: Huang, Weihua, et al.
Publicado: (2020)

736. Risk Factors and Outcomes Associated with Daptomycin-nonsusceptible Enterococcus Bloodstream Infections
por: Failla, Andrew J, et al.
Publicado: (2023)

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus
por: Greene, Matthew H, et al.
Publicado: (2018)

1573. Daptomycin Resistant Enterococcus faecium: Combination Therapy Screening
por: Kebriaei, Razieh, et al.
Publicado: (2020)

1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam
por: Kebriaei, Razieh, et al.
Publicado: (2019)

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015)

Acquisition of Daptomycin Resistance by Enterococcus faecium Confers Collateral Sensitivity to Glycopeptides
por: Zeng, Weiliang, et al.
Publicado: (2022)

Intrathecal daptomycin use in a challenging case of Enterococcus faecium ventriculitis
por: Dhariwal, Ankush, et al.
Publicado: (2022)

De Novo Daptomycin-Nonsusceptible Enterococcal Infections
por: Kelesidis, Theodoros, et al.
Publicado: (2012)

1399. Efficacy of Daptomycin Combination with β-Lactams for Daptomycin-resistant Enterococcus faecium Harboring LiaSR Substitutions
por: Kebriaei, Razieh, et al.
Publicado: (2018)

New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
por: Li, Weiwei, et al.
Publicado: (2022)

Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance
por: Sinel, Clara, et al.
Publicado: (2017)

Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
por: Echeverría-Esnal, Daniel, et al.
Publicado: (2021)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
por: Pincus, Nathan B., et al.
Publicado: (2022)

601. TelA and XpaC Are Novel Mediators of Daptomycin Resistance in Enterococcus faecium
por: Tran, Truc T, et al.
Publicado: (2019)

Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium
por: Kinnear, Clare L., et al.
Publicado: (2020)

In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains
por: Chen, Zhong, et al.
Publicado: (2022)

Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus
por: Ma, Zhuo, et al.
Publicado: (2018)

Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure
por: Bhardwaj, Pooja, et al.
Publicado: (2017)

A Whole Genome Sequencing (WGS) Approach to Predict Daptomycin (DAP) Susceptibility of Enterococcus faecium
por: Contreras, German, et al.
Publicado: (2017)

1019. Treatment Outcomes for Enterococcus faecium Bacteremia in Solid-Organ Transplant Patients: Implications for Daptomycin
por: Mercuro, Nicholas J, et al.
Publicado: (2018)

Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy
por: Matono, Takashi, et al.
Publicado: (2016)

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)

Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
por: Chacko, Kieran I., et al.
Publicado: (2018)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
por: Chen, Liang-Yu, et al.
Publicado: (2011)

The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An In Vitro Study
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis
por: Miller, Christopher R, et al.
Publicado: (2019)

Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient
por: Eden, Gabriele, et al.
Publicado: (2012)

Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin
por: Hussain, Khandakar, et al.
Publicado: (2016)

Genomic Pathways Associated with Daptomycin (DAP) Resistance in DAP-Susceptible Enterococcus faecium Harboring Substitutions in LiaFSR
por: Tran, Truc T, et al.
Publicado: (2017)

1221. Genomic Factors Affecting the Efficacy of Antimicrobial Therapy in Daptomycin-, Linezolid-, Vancomycin-Resistant Enterococcus faecium (DLVRE)
por: Gatesy, Samuel W, et al.
Publicado: (2021)

Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility
por: Coyne, Ashlan J. Kunz, et al.
Publicado: (2022)

Enterovirus D68 Subclade B3 Strain Circulating and Causing an Outbreak in the United States in 2016
por: Wang, Guiqing, et al.
Publicado: (2017)

711. Molecular Epidemiology of Daptomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Sundaram, Ayesha, et al.
Publicado: (2018)

2452. Treatment and Outcomes of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Hadid, Hind, et al.
Publicado: (2018)

197. Evaluation of Risk Factors and Outcomes Associated with Daptomycin-nonsusceptible Staphylococcus aureus Bacteremia
por: Hanna, Zachary W, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9lnlpnb6991487t4t89t8j1nv4